期刊文献+
共找到151篇文章
< 1 2 8 >
每页显示 20 50 100
Design,delivery and efficacy testing of therapeutic nucleic acids used to inhibit hepatitis C virus gene expression in vitro and in vivo 被引量:9
1
作者 Wolfgang H.Caselmann Matthias Serwe +3 位作者 Thomas Lehmann János Ludwig Brian S.Sproat Joachim W.Engels 《World Journal of Gastroenterology》 SCIE CAS CSCD 2000年第5期626-629,共4页
Despite major achievements in the treatment ofchronic hepatitis C with the combination ofinterferons and the nucleoside analog ribavirin themajority of patients with chronic hepatitis C virus(HCV) infection cannot be ... Despite major achievements in the treatment ofchronic hepatitis C with the combination ofinterferons and the nucleoside analog ribavirin themajority of patients with chronic hepatitis C virus(HCV) infection cannot be treated effectively.Toimprove this response rate we used antisensetechnologies to inhibit HCV translation as possibleadditional option for experimental treatment.Antisense oligodeoxynucleotides(ODN) are 展开更多
关键词 hepatitis C-like viruses/therapy gene expression in VITRO in vivo nucleic acids/therapeutic use CYTOMEGALOVIRUS
下载PDF
Therapeutic and Medicinal Uses of <i>Aloe vera</i>: A Review 被引量:5
2
作者 Pankaj K. Sahu Deen Dayal Giri +5 位作者 Ritu Singh Priyanka Pandey Sharmistha Gupta Atul Kumar Shrivastava Ajay Kumar Kapil Dev Pandey 《Pharmacology & Pharmacy》 2013年第8期599-610,共12页
The plant Aloe vera is used in Ayurvedic, Homoeopathic and Allopathic streams of medicine, and not only tribal community but also most of the people for food and medicine. The plant leaves contains numerous vitamins, ... The plant Aloe vera is used in Ayurvedic, Homoeopathic and Allopathic streams of medicine, and not only tribal community but also most of the people for food and medicine. The plant leaves contains numerous vitamins, minerals, enzymes, amino acids, natural sugars and other bioactive compounds with emollient, purgative, anti-microbial, anti inflammatory, antioxidant, aphrodisiac, anti-helmenthic, antifungal, antiseptic and cosmetic values for health care. This plant has potential to cure sunburns, burns and minor cuts, and even skin cancer. The external use in cosmetic primarily acts as skin healer and prevents injury of epithelial tissues, cures acne and gives a youthful glow to skin, also acts as extremely powerful laxative. 展开更多
关键词 ALOE vera Antimicrobial therapeutic MEDICINAL useS Cosmetic Application
下载PDF
Continuous Wear of Hydrogel Contact Lenses for Therapeutic Use
3
作者 Daisuke Kudo Hiroshi Toshida +1 位作者 Toshihiko Ohta Akira Murakami 《Open Journal of Ophthalmology》 2012年第4期110-113,共4页
Purpose: To investigate the efficacy and complications of continuous wear of etafilcon A for therapeutic use. Materials and Methods: The subjects were 228 eyes of 219 outpatients prescribed contact lens (CL) for one w... Purpose: To investigate the efficacy and complications of continuous wear of etafilcon A for therapeutic use. Materials and Methods: The subjects were 228 eyes of 219 outpatients prescribed contact lens (CL) for one week of continuous therapeutic wear during 10 years. The reason for prescription of CLs, the primary disease, the duration of CL wear and the complications were assessed retrospectively. Results: The predominant reason for prescription of CLs was relief of pain or a foreign-body sensation (62.3%) and protection of the corneal epithelium (20.6%). The primary disease was post-penetrating keratoplasty (36.8%), followed by corneal epithelial erosion (14.5%), post-lamellar keratoplasty (14.0%) and bullous keratopathy (12.2%). The average duration of wearing single lens was 6.5 ± 3.2 days. The average duration of wearing CLs in total was 9.2 ± 10.7 months. The most frequent problem associated with continuous wear of CLs was their dropping out of CLs (12.3%). The complications associated with CLs included conjunctivitis with papillary hyperplasia, corneal erosion and superficial punctate keratitis, but corneal ulcer and corneal infiltrates were not found. Conclusion: Serious complications were not shown changing the lenses every week to keep to the prescribed time limit for continuous therapeutic wear, even if corneal epithelial barrier function is impaired. 展开更多
关键词 therapeutic use BANDAGE Soft Contact LENS CONTINUOUS WEAR COMPLICATION
下载PDF
Comparison of long-lasting therapeutic effects between succimer and penicillamine on hepatolenticular degeneration 被引量:3
4
作者 REN Ming Shan, ZHANG Zhi, WU Jun Xia, LI Fei, XUE Ben Chun and YANG Ren Min 《World Journal of Gastroenterology》 SCIE CAS CSCD 1998年第6期75-77,共3页
AIM To compare the long term effect of succimer (Suc) with that of penicillamine (Pen) in treating hepatolenticular degeneration (HLD). METHODS One hundred and twenty patients with HLD were divided into 2 groups. ... AIM To compare the long term effect of succimer (Suc) with that of penicillamine (Pen) in treating hepatolenticular degeneration (HLD). METHODS One hundred and twenty patients with HLD were divided into 2 groups. Group A ( n =60) received Suc 750mg , po. bid. Group B ( n =60) received Pen 250mg , po. qid. The period of maintenance treatment varied from 6 months to 3 years, averaging 1 5 years. Symptoms and therapeutic effects were evaluated by modified Goldstein scale. RESULTS The total effectiveness of group A in two different periods of treatment were 80% and 85% respectively, higher than those of group B (58% and 59% respectively) ( P <0 05). Suc also had obvious curative effects for the patients who failed in the use of Pen. There were fewer side effect in group A than in group B ( P <0 05). Suc and Pen could increase urinary copper excretion effectively and continually. CONCLUSION Suc is more effective and safer than Pen. Clinically, it can replace Pen as first choice drug for long term maintenance therapy of HLD. 展开更多
关键词 hepatolenticular degeneration/drug THERAPY succimer/therapeutic use penicillamine/therapeutic use
下载PDF
Functional dyspepsia of ulcer-dysmotility type:clinical incidence and therapeutic strategy 被引量:3
5
作者 WANG XiaoZhong and LIN GuZhen 《World Journal of Gastroenterology》 SCIE CAS CSCD 1998年第4期95-96,共2页
Functionaldyspepsiaofulcerdysmotilitytype:clinicalincidenceandtherapeuticstrategyWANGXiaoZhongandLINGuZhe... Functionaldyspepsiaofulcerdysmotilitytype:clinicalincidenceandtherapeuticstrategyWANGXiaoZhongandLINGuZhenSubjectheaadings... 展开更多
关键词 dyspepsia/drug therapy famotidine/therapeutic use cisapride/therapeutic use peptic ULCER gastrointestinal motility
下载PDF
Therapeutic role of template-based lymphadenectomy in urothelial carcinoma of the upper urinary tract 被引量:5
6
作者 Tsunenori Kondo Toshio Takagi Kazunari Tanabe 《World Journal of Clinical Oncology》 CAS 2015年第6期237-251,共15页
Lymphadenectomy for urothelial carcinoma of the upper urinary tract has attracted the attention of physicians. The mapping study of lymphatic spread has shown that a relatively wide area should comprise the regional n... Lymphadenectomy for urothelial carcinoma of the upper urinary tract has attracted the attention of physicians. The mapping study of lymphatic spread has shown that a relatively wide area should comprise the regional nodes for tumors of the right renal pelvis or the right upper two-thirds of the ureter. A prospective study showed that an anatomical templatebased lymphadenectomy significantly improved patient survival in tumors of the renal pelvis. This benefit was more evident for patients with p T2 stage tumors or higher. The risk of regional node recurrence is significant reduced by template-based lymphadenectomy,which is likely to be associated with improved patient survival. The removal of lymph node micrometastases is assumed to be the reason for therapeutic benefit following lymphadenectomy. The number of resected lymph nodes can be used to assess the quality of lymphadenectomy,but not to determine the extent of lymphadenectomy. The guidelines currently recommend lymphadenectomy for patients with muscle-invasive disease,even though the current recommendation grades are still low. The present limitation of lymphadenectomy is the lack of standardization of the extent of lymphadenectomy and the randomized trials. Further studies are warranted to collect the evidence to support lymphadenectomy. 展开更多
关键词 LYMPHADENECTOMY LYMPH node EXCISION UROTHELIAL carcinoma Treatment outcome therapeutic uses Diagnosis GUIDELINE
下载PDF
Blastocystis hominis as a cause of chronic diarrhea in low-resource settings:A systematic review
7
作者 Stephen Amoak Jonathan Soldera 《World Journal of Meta-Analysis》 2024年第3期30-41,共12页
BACKGROUND Blastocystis hominis(B.hominis),an anaerobic unicellular protist parasite,is known for its diverse clinical manifestations upon infecting the human gastrointestinal tract.Although globally distributed,it is... BACKGROUND Blastocystis hominis(B.hominis),an anaerobic unicellular protist parasite,is known for its diverse clinical manifestations upon infecting the human gastrointestinal tract.Although globally distributed,it is particularly prevalent in developing nations.Examining the symptoms and treatment outcomes of B.hominis infection in low-resource settings holds immense significance,providing healthcare practi-tioners with valuable insights to enhance patient care.AIM To synthesize existing evidence on the symptomatology and treatment outcomes of B.hominis infection in low-resource settings.METHODS Following the Preferred Reporting Items for Systematic Review and Meta-Analysis guidelines,a systematic review was conducted.The search spanned electronic databases including PubMed,Scopus,and Google Scholar.After a comprehensive screening process,a thorough examination of the papers,adhering to inclusion and exclusion criteria,and data extraction from eligible studies was conducted.The findings underwent summarization through simple descriptive analysis.RESULTS The search yielded 1200 papers,with 17 meeting inclusion criteria.Chronic diarrhea due to B.hominis infection was reported in only two studies,while abdominal pain,diarrhea,flatulence,constipation,and nausea/vomiting emerged as the most commonly documented symptoms.Recovery rates after one week of treatment ranged from 71.8%to 100%,and after two weeks,from 60%to 100%.CONCLUSION In low-resource settings,chronic diarrhea resulting from B.hominis infection is infrequent.Common symptoms include abdominal pain,diarrhea,flatulence,constipation,and nausea/vomiting.Post-treatment,clinical outcomes are notably favorable,supporting the recommendation for treatment.Metronidazole is advocated as the first-line agent,with consideration for switching to a second-line option in cases of treatment failure or poor response. 展开更多
关键词 Blastocystis infections Gastrointestinal diseases Treatment outcome Developing countries Metronidazole/therapeutic use
下载PDF
Clinacanthus nutans:a review of the medicinal uses,pharmacology and phytochemistry 被引量:10
8
作者 Md.Ariful Alam Sahena Ferdosh +4 位作者 Kashif Ghafoor Md.Abdul Hakim Abdul Shukor Juraimi Alfi Khatib Md.Zaidul I.Sarker 《Asian Pacific Journal of Tropical Medicine》 SCIE CAS 2016年第4期393-399,共7页
Clinacanthus nutans Lindau is known as snake grass belonging to the Acanlhaceae family.This plant has diverse and potential medicinal uses in traditional herbal medicine for treating skin rashes,insects and snake bite... Clinacanthus nutans Lindau is known as snake grass belonging to the Acanlhaceae family.This plant has diverse and potential medicinal uses in traditional herbal medicine for treating skin rashes,insects and snake bites,lesions caused by herpes simplex virus,diabetes,and gout in Malaysia.Indonesia.Thailand and China.Phylochemieal investigations documented the varied contents of bioaclive compounds from litis plant namely flavonoids,glycosides,glycoglyeerolipids.cerebrosides and monoacylmonogalatosylglycerol.The pharmacological experiment proved that various types of extracts and pure compounds from this species exhibited a broad range of biological properties such as anti-inflammatory,antiviral,antioxidant,and anti-diabetic activities.The lindings of toxicity study showed that extracts from this plant did not show any toxicity thus it can be used as strong therapeutic agents for specific diseased conditions.However,further experiments on chemical components and their mode of action showing biological activities are required to elucidate the complete phytochemical profile and assess to confirm their suitability tor future drugs.This review summarizes the medicinal uses,phytochemistry and pharmacology of this plant in order to explore its therapeutic potential and gaps necessitating for prospected research work. 展开更多
关键词 Clinacanthus nutans MEDICINAL useS PHYTOCHEMICALS PHARMACOLOGY therapeutic potential
下载PDF
High-intensity focused ultrasound extracorporeal ablation of liver tissuesin rabbits
9
《World Journal of Gastroenterology》 SCIE CAS CSCD 1998年第2期16-16,共1页
HighintensityfocusedultrasoundextracorporealablationoflivertissuesinrabbitsCHENGShuQun1,ZHOUXinDa1,TANGZ... HighintensityfocusedultrasoundextracorporealablationoflivertissuesinrabbitsCHENGShuQun1,ZHOUXinDa1,TANGZhaoYou1,YUYao1,B... 展开更多
关键词 LIVER neoplasms experimental/therapy ultrasonic THERAPY iodized oil/therapeutic use liver/radiation effects randomized controlled trials
下载PDF
布地奈德联合氨溴索对儿童急性支气管炎症状改善及机体炎症反应的影响
10
作者 何军 《中外医疗》 2024年第29期100-102,137,共4页
目的探究布地奈德联合氨溴索对儿童急性支气管炎症状改善及机体炎症反应的影响。方法随机选取2023年6—11月滕州市妇幼保健院收治的100例儿童急性支气管炎患儿为研究对象,根据不同用药方案分为常规组和研究组,每组50例。常规组采用氨溴... 目的探究布地奈德联合氨溴索对儿童急性支气管炎症状改善及机体炎症反应的影响。方法随机选取2023年6—11月滕州市妇幼保健院收治的100例儿童急性支气管炎患儿为研究对象,根据不同用药方案分为常规组和研究组,每组50例。常规组采用氨溴索治疗,研究组采用氨溴索与布地奈德联合治疗。对比两组患儿的治疗总有效率、临床症状改善时间、治疗前后炎症介质水平。结果研究组治疗总有效率为98.00%(49/50),高于常规组的80.00%(40/50),差异有统计学意义(χ^(2)=8.274,P=0.004)。研究组喘鸣音改善时间、咳嗽改善时间、气促改善时间及湿啰音消失时间均短于常规组,差异有统计学意义(P均<0.05)。治疗前,两组患儿的炎症介质水平对比,差异无统计学意义(P>0.05);治疗后,研究组炎症介质水平低于常规组,差异有统计学意义(P<0.05)。结论对儿童急性支气管炎患儿使用布地奈德联合氨溴索治疗,能减轻机体炎症反应,缩短症状改善时间。 展开更多
关键词 儿童急性支气管炎 布地奈德 氨溴索 治疗效果
下载PDF
乙酰半胱氨酸联合布地奈德雾化吸入治疗对新生儿肺炎的效果分析
11
作者 李秀洪 魏春晖 陈强 《中外医疗》 2024年第16期86-89,共4页
目的 探析乙酰半胱氨酸联合布地奈德经雾化吸入治疗对新生儿肺炎的效果。方法 回顾性选取宁德师范学院附属宁德市医院于2020年12月—2023年12月收治的72例新生儿肺炎患儿的临床资料,按治疗措施不同分为对照组(n=36)和观察组(n=36),对照... 目的 探析乙酰半胱氨酸联合布地奈德经雾化吸入治疗对新生儿肺炎的效果。方法 回顾性选取宁德师范学院附属宁德市医院于2020年12月—2023年12月收治的72例新生儿肺炎患儿的临床资料,按治疗措施不同分为对照组(n=36)和观察组(n=36),对照组给予布地奈德治疗,观察组给予乙酰半胱氨酸联合布地奈德治疗。比较两组治疗效果。结果 观察组治疗总有效率为97.22%,高于对照组的75.00%,差异有统计学意义(χ^(2)=3.960,P<0.05)。观察组临床症状消失时间、血清炎症因子水平、血气指标优于对照组,差异有统计学意义(P均<0.05)。结论 在新生儿肺炎患儿治疗期间应用乙酰半胱氨酸联合布地奈德雾化吸入效果理想,可以缩短临床症状消失时间,还能降低炎症因子水平,改善血气分析指标。 展开更多
关键词 乙酰半胱氨酸 布地奈德 雾化吸入 新生儿肺炎 治疗效果
下载PDF
布地奈德/福莫特罗与糖皮质激素治疗EOS增多表型和非EOS增多表型AECOPD的短期疗效比较 被引量:1
12
作者 艾力扎提·艾则孜 周海霞 +2 位作者 罗茜 张杰 李争争 《疑难病杂志》 CAS 2024年第10期1216-1220,共5页
目的观察布地奈德/福莫特罗与糖皮质激素(GC)治疗嗜酸性粒细胞(EOS)增多表型和非EOS增多表型慢性阻塞性肺疾病急性加重期(AECOPD)的短期疗效比较。方法选取2020年6月—2023年6月中国人民解放军新疆军区总医院呼吸内科诊治的AECOPD患者16... 目的观察布地奈德/福莫特罗与糖皮质激素(GC)治疗嗜酸性粒细胞(EOS)增多表型和非EOS增多表型慢性阻塞性肺疾病急性加重期(AECOPD)的短期疗效比较。方法选取2020年6月—2023年6月中国人民解放军新疆军区总医院呼吸内科诊治的AECOPD患者168例,根据EOS比例分为EOS增多表型组(EOS>2%,n=42)、非EOS增多表型组(EOS≤2%,n=126);EOS增多表型组随机分为Ⅰ亚组(n=21)、Ⅱ亚组(n=21),非EOS增多表型组随机分为Ⅲ亚组(n=63)、Ⅳ亚组(n=63)。Ⅰ、Ⅲ亚组给予布地奈德/福莫特罗吸入治疗,Ⅱ、Ⅳ亚组口服或静脉滴注GC治疗。比较入院时、治疗5 d后静脉血EOS计数、血气分析指标[氧合指数(PaO_(2)/FiO_(2))、动脉血二氧化碳分压(PaCO_(2))]、慢性阻塞性肺疾病评估测试量表(CAT)评分及住院时间。结果治疗5 d后,Ⅰ亚组、Ⅱ亚组静脉血EOS计数低于入院时,且Ⅱ亚组静脉血EOS计数低于Ⅰ亚组(t/P=2.641/0.012),Ⅲ、Ⅳ亚组静脉血EOS计数比较差异无统计学意义(P>0.05);治疗5 d后,Ⅱ亚组PaO_(2)/FiO_(2)高于Ⅰ亚组,PaCO_(2)、CAT评分低于Ⅰ亚组(t/P=4.331/<0.001,3.351/0.002,2.884/0.006),而Ⅲ亚组、Ⅳ亚组PaO_(2)/FiO_(2)、PaCO_(2)、CAT评分差异无统计学意义(P>0.05);治疗5 d后,Ⅰ亚组PaO_(2)/FiO_(2)高于Ⅲ亚组,PaCO_(2)、CAT评分低于Ⅲ亚组(t/P=8.856/<0.001,6.588/<0.001,1.964/0.049),Ⅱ亚组PaO_(2)/FiO_(2)高于Ⅳ亚组,PaCO_(2)、CAT评分低于Ⅳ亚组(t/P=12.456/<0.001,10.350/<0.001,5.356/<0.001);Ⅱ亚组住院时间短于Ⅰ亚组(t/P=2.718/0.010),Ⅰ亚组住院时间短于Ⅲ亚组(t/P=4.394/0.010),Ⅱ亚组住院时间短于Ⅳ亚组(t/P=6.700/<0.001)。结论EOS增多表型AECOPD患者,GC全身给药短期疗效均优于布地奈德/福莫特罗雾化吸入,而非EOS增多表型AECOPD患者,雾化吸入疗法和GC全身给药短期疗效相似,雾化吸入疗法可替代GC全身给药。 展开更多
关键词 慢性阻塞性肺疾病急性加重期 嗜酸性粒细胞表型 布地奈德/福莫特罗 糖皮质激素 雾化吸入 全身性应用 嗜酸性粒细胞 血气分析
下载PDF
Controversies regarding transplantation of mesenchymal stem cells
13
作者 Tsvetelina Velikova Tereza Dekova Dimitrina Georgieva Miteva 《World Journal of Transplantation》 2024年第2期48-61,共14页
Mesenchymal stem cells(MSCs)have tantalized regenerative medicine with their therapeutic potential,yet a cloud of controversies looms over their clinical tran-splantation.This comprehensive review navigates the intric... Mesenchymal stem cells(MSCs)have tantalized regenerative medicine with their therapeutic potential,yet a cloud of controversies looms over their clinical tran-splantation.This comprehensive review navigates the intricate landscape of MSC controversies,drawing upon 15 years of clinical experience and research.We delve into the fundamental properties of MSCs,exploring their unique immuno-modulatory capabilities and surface markers.The heart of our inquiry lies in the controversial applications of MSC transplantation,including the perennial debate between autologous and allogeneic sources,concerns about efficacy,and lingering safety apprehensions.Moreover,we unravel the enigmatic mechanisms surro-unding MSC transplantation,such as homing,integration,and the delicate balance between differentiation and paracrine effects.We also assess the current status of clinical trials and the ever-evolving regulatory landscape.As we peer into the future,we examine emerging trends,envisioning personalized medicine and innovative delivery methods.Our review provides a balanced and informed perspective on the controversies,offering readers a clear understanding of the complexities,challenges,and potential solutions in MSC transplantation. 展开更多
关键词 Mesenchymal stem cells Transplantation controversies Regenerative medicine Autoimmune diseases Chronic inflammatory illnesses Tumor growth METASTASIS therapeutic potential Clinical use of mesenchymal stem cell
下载PDF
沙丁胺醇联合布地奈德雾化吸入治疗支气管哮喘合并肺部感染的临床效果
14
作者 李红妹 《临床合理用药杂志》 2024年第8期25-28,共4页
目的观察沙丁胺醇联合布地奈德雾化吸入治疗支气管哮喘合并肺部感染的临床效果。方法选取2019年1月—2022年6月玉林市红十字会医院收治的支气管哮喘合并肺部感染患者136例,采用随机数字表法分为观察组和对照组,各68例。在常规治疗基础上... 目的观察沙丁胺醇联合布地奈德雾化吸入治疗支气管哮喘合并肺部感染的临床效果。方法选取2019年1月—2022年6月玉林市红十字会医院收治的支气管哮喘合并肺部感染患者136例,采用随机数字表法分为观察组和对照组,各68例。在常规治疗基础上,对照组予吸入用布地奈德混悬液治疗,观察组在对照组基础上加吸入用硫酸沙丁胺醇溶液治疗,2组均持续治疗2周。比较2组患者的临床疗效、临床表现(呼吸困难、咳嗽、喘息、气急及哮鸣音)持续时间、治疗前后气道重塑指标[转化生长因子-β(TGF-β)、基质金属蛋白酶因子-9(MMP-9)、基质金属蛋白酶抑制因子-1(TIMP-1)]、治疗前后肺功能指标[用力肺活量(FVC)、呼气流量峰值(PEF)、第1秒用力呼气容积(FEV 1)]及不良反应。结果观察组患者治疗总有效率为98.53%,高于对照组的82.35%(χ2=10.291,P=0.001);观察组患者呼吸困难、咳嗽、喘息、气急以及哮鸣音等表现持续时间均短于对照组(P均<0.01);治疗后,2组血清TGF-β、MMP-9、TIMP-1水平均较治疗前降低,FVC、PEF、FEV 1均较治疗前增加,且观察组变化大于对照组(P均<0.01);观察组患者未出现不良反应,对照组患者中出现轻度头痛1例(1.47%),2组比较差异无统计学意义(P=1.000)。结论沙丁胺醇联合布地奈德雾化吸入治疗支气管哮喘合并肺部感染的临床效果肯定,可促进患者气道重塑和肺功能恢复,且安全性高。 展开更多
关键词 支气管哮喘 肺部感染 布地奈德 沙丁胺醇 雾化吸入 治疗效果 安全性
下载PDF
对支气管哮喘采用布地奈德气雾剂(小剂量)治疗的效果分析
15
作者 柳舟 刘顺 《系统医学》 2024年第2期118-120,124,共4页
目的探讨对支气管哮喘采用布地奈德气雾剂进行治疗的临床效果。方法选取2020年2月—2022年12月单县中心医院收治的62例支气管哮喘患者为研究对象,采用投掷硬币法分为两组。参照组(n=31)施以常规药物治疗;研究组(n=31)在参照组基础上给... 目的探讨对支气管哮喘采用布地奈德气雾剂进行治疗的临床效果。方法选取2020年2月—2022年12月单县中心医院收治的62例支气管哮喘患者为研究对象,采用投掷硬币法分为两组。参照组(n=31)施以常规药物治疗;研究组(n=31)在参照组基础上给予布地奈德气雾剂治疗。比较两组治疗效果。结果研究组治疗总有效率(96.77%)高于参照组(74.19%),差异有统计学意义(χ^(2)=6.369,P<0.05)。治疗后,研究组肺功能指标优于参照组;喘憋减轻时间、肺部哮鸣音减轻时间以及住院时间均短于参照组,差异有统计学意义(P均<0.05)。结论临床对支气管哮喘患者合理选择布地奈德气雾剂展开治疗,可明显提升疗效,显著提升患者的肺功能水平,可促进支气管哮喘患者的良好预后。 展开更多
关键词 支气管哮喘 布地奈德气雾剂(小剂量) 治疗效果 肺功能指标
下载PDF
USE OF CELL-BASED BIOASSAY FOR THE QUALITY CONTROL OF BOTANICAL THERAPEUTICS
16
作者 Doo Suk Lee Min-Jung Bae Sunyoung Kim 《World Journal of Traditional Chinese Medicine》 2015年第4期91-91,共1页
The single most important factor in modernization efforts of traditional oriental medicines is the limited understanding of active compounds responsible for claimed therapeutic effects.Indeed,the unknown identity of b... The single most important factor in modernization efforts of traditional oriental medicines is the limited understanding of active compounds responsible for claimed therapeutic effects.Indeed,the unknown identity of biologically active molecules generates major difficulties associated with botanical therapeutics in general.This includes management of raw materials,poor understanding of 展开更多
关键词 use OF CELL-BASED BIOASSAY FOR THE QUALITY CONTROL OF BOTANICAL therapeuticS PG
原文传递
布地奈德雾化吸入对小儿哮喘急性发作的临床观察 被引量:59
17
作者 张义堂 王中晓 杨红 《中国药房》 CAS 北大核心 2017年第5期660-663,共4页
目的:观察布地奈德雾化吸入对小儿哮喘急性发作的疗效与安全性。方法:选取2014年1月-2016年5月我院诊治的哮喘急性发作患儿90例,采用随机数字表法分为观察组和对照组,各45例。对照组患儿给予炎琥宁氯化钠注射液10mg/(kg·d),ivgtt,... 目的:观察布地奈德雾化吸入对小儿哮喘急性发作的疗效与安全性。方法:选取2014年1月-2016年5月我院诊治的哮喘急性发作患儿90例,采用随机数字表法分为观察组和对照组,各45例。对照组患儿给予炎琥宁氯化钠注射液10mg/(kg·d),ivgtt,qd+阿奇霉素注射液10 mg/(kg·d),ivgtt,qd抗感染等常规治疗;观察组患儿在此基础上给予布地奈德气雾剂0.5 mg,雾化吸入,bid。两组患儿均连续治疗7 d。观察患儿的临床疗效、肺功能指标、T细胞亚群水平、症状缓解时间,并记录不良反应发生情况。结果:观察组患儿的总有效率(91.11%)明显高于对照组(71.11%),差异有统计学意义(P<0.05);治疗后,观察组患儿肺功能指标用力肺活量(FVC)、第1秒用力呼气容积(FEV1)、FEV1/FVC均明显高于对照组,差异有统计学意义(P<0.05);观察组患儿CD3^+、CD4^+和CD4^+/CD8^+均明显升高,CD8^+明显降低,且观察组患儿上述指标较对照组改善更明显,差异均有统计学意义(P<0.05)。观察组患儿喘息、咳嗽、呼吸困难和肺部哮鸣音等临床症状缓解时间均明显短于对照组,差异有统计学意义(P<0.05)。两组患儿不良反应发生率比较,差异无统计学意义(P>0.05)。结论:布地奈德雾化吸入对小儿哮喘急性发作的疗效明显,且安全性好。 展开更多
关键词 布地奈德 小儿哮喘 急性发作 雾化吸入 疗效
下载PDF
布地奈德联合沙丁胺醇治疗婴幼儿毛细支气管炎的临床观察 被引量:40
18
作者 杨丽 金英姬 张亚明 《中国药房》 CAS 北大核心 2017年第20期2817-2819,共3页
目的:探讨在沙丁胺醇基础上加用布地奈德治疗婴幼儿毛细支气管炎的疗效、安全性和经济性。方法:采用前瞻性研究方法,选择2014年10月-2016年4月我院毛细支气管炎的住院患儿160例。按入院号顺序,单号为观察组,双号为对照组,各80例。两组... 目的:探讨在沙丁胺醇基础上加用布地奈德治疗婴幼儿毛细支气管炎的疗效、安全性和经济性。方法:采用前瞻性研究方法,选择2014年10月-2016年4月我院毛细支气管炎的住院患儿160例。按入院号顺序,单号为观察组,双号为对照组,各80例。两组患儿均给予常规治疗。对照组患儿给予吸入用硫酸沙丁胺醇溶液0.25 m L加入0.9%氯化钠注射液3 m L,q8 h;观察组患儿给予吸入用布地奈德混悬液2 m L+吸入用硫酸沙丁胺醇溶液0.25 m L加入0.9%氯化钠注射液1 m L,q8 h;两组患儿均采用氧气驱动雾化吸入,均连续治疗5~7 d。观察两组患儿临床症状消失时间、住院时间、临床疗效,比较治疗药品(雾化吸入药品和其他治疗药品)费用,并记录不良反应发生情况。结果:两组患儿咳嗽消失时间、喘息消失时间、啰音消失时间、三凹征消失时间和住院时间比较,差异均无统计学意义(P>0.05);观察组患儿的临床总有效率(95.00%)与对照组(92.50%)比较,差异无统计学意义(P>0.05);观察组患儿雾化吸入药品费用[(355.77±10.98)元]明显高于对照组[(26.83±2.86)元],差异有统计学意义(P<0.05);两组患儿常规治疗药品费用比较,差异无统计学意义(P>0.05);两组患儿治疗期间均未见明显不良反应发生。结论:在沙丁胺醇基础上雾化吸入布地奈德治疗婴幼儿毛细支气管炎并不能显著减轻病情、缩短住院时间和提高临床疗效,但增加了治疗费用。 展开更多
关键词 毛细支气管炎 布地奈德 沙丁胺醇 婴幼儿 雾化吸入 疗效 药品费用
下载PDF
布地奈德混悬液治疗婴幼儿哮喘急性发作 被引量:6
19
作者 李增清 陈永新 +3 位作者 蒙秀玲 张宇昕 刘辉芳 孙跃玉 《湖南中医药大学学报》 CAS 2011年第6期37-38,共2页
目的观察布地奈德混悬液(令舒)治疗婴幼儿哮喘急性发作的疗效。方法 160例哮喘患儿随机分为治疗组和对照组,两组均给予β2受体激动剂、茶碱等治疗,治疗组在此基础上,加入布地奈德混悬液治疗。结果临床症状减轻或消失时间较对照组短,差... 目的观察布地奈德混悬液(令舒)治疗婴幼儿哮喘急性发作的疗效。方法 160例哮喘患儿随机分为治疗组和对照组,两组均给予β2受体激动剂、茶碱等治疗,治疗组在此基础上,加入布地奈德混悬液治疗。结果临床症状减轻或消失时间较对照组短,差异有统计学意义(P<0.05)。结论布地奈德混悬液临床疗效好,起效快,且作用持久,不良反应少,值得临床推广。 展开更多
关键词 布地奈德混悬液 婴幼儿哮喘 治疗效果
下载PDF
布地奈德鼻喷雾剂联合孟鲁司特钠治疗变应性鼻炎的疗效观察 被引量:18
20
作者 詹飞 陈锋 《河北医学》 CAS 2018年第7期1210-1213,共4页
目的:探讨布地奈德鼻喷雾剂联合孟鲁司特钠治疗变应性鼻炎的疗效。方法:收集我院2013年9月至2015年5月收治的变应性鼻炎患者90例前瞻性研究且随机分为两组,每组45人,A组患者给予布地奈德+氯雷他定,B组患者给予布地奈德+孟鲁司特钠,比较... 目的:探讨布地奈德鼻喷雾剂联合孟鲁司特钠治疗变应性鼻炎的疗效。方法:收集我院2013年9月至2015年5月收治的变应性鼻炎患者90例前瞻性研究且随机分为两组,每组45人,A组患者给予布地奈德+氯雷他定,B组患者给予布地奈德+孟鲁司特钠,比较两组患者临床症状评分与治疗效果。结果:A组患者治疗后鼻塞评分(0.81±0.18)、鼻痒评分(0.61±0.19)、喷嚏评分(0.57±0.15)与流涕评分(0.34±0.13)均显著性高于B组(0.56±0.15,0.46±0.11,0.41±0.12,0.21±0.08),存在显著性差异(t=12.451,9.261,7.051,5.337),具有统计学意义(P<0.01);A组患者总有效率(75.56%)明显低于B组(93.33%),存在明显差异(χ2=5.414),具有统计学意义(P<0.05)。结论:相比较布地奈德+氯雷他定的治疗效果,布地奈德+孟鲁司特钠对变应性鼻炎患者治疗最为显著,具有借鉴性。 展开更多
关键词 布地奈德 氯雷他定 孟鲁司特钠 疗效
下载PDF
上一页 1 2 8 下一页 到第
使用帮助 返回顶部